Literature DB >> 16916762

Dendritic cells and tumor microenvironment: a dangerous liaison.

Ingo Fricke1, Dmitry I Gabrilovich.   

Abstract

The fact that the immune response to cancer is compromised has been convincingly demonstrated in murine tumor models as well as in cancer patients. The unresponsiveness of the host immune system is one of the major mechanisms of tumor escape as well as an important factor that limits the success of cancer immunotherapy. Inadequate function of professional antigen presenting cells dendritic cells (DC) in cancer is one of the major elements of compromised anti-tumor immune response. Despite substantial progress in recent years, the mechanism of inadequate DC function in cancer still remains unclear. The tumor microenvironment has emerged as an important component contributing to DC malfunction. In this review we will discuss the potential role of tumor microenvironment in DC dysfunction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16916762      PMCID: PMC1994724          DOI: 10.1080/08820130600803429

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  171 in total

Review 1.  Signaling of transforming growth factor-beta family members through Smad proteins.

Authors:  S Itoh; F Itoh; M J Goumans; P Ten Dijke
Journal:  Eur J Biochem       Date:  2000-12

Review 2.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

3.  SOCS-1 participates in negative regulation of LPS responses.

Authors:  Reiko Nakagawa; Tetsuji Naka; Hiroko Tsutsui; Minoru Fujimoto; Akihiro Kimura; Tatsuo Abe; Ekihiro Seki; Shintaro Sato; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira; Koichi Yamanishi; Ichirou Kawase; Kenji Nakanishi; Tadamitsu Kishimoto
Journal:  Immunity       Date:  2002-11       Impact factor: 31.745

4.  Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation.

Authors:  A Rosendahl; D Checchin; T E Fehniger; P ten Dijke; C H Heldin; P Sideras
Journal:  Am J Respir Cell Mol Biol       Date:  2001-07       Impact factor: 6.914

5.  Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function.

Authors:  G V Shurin; M R Shurin; S Bykovskaia; J Shogan; M T Lotze; E M Barksdale
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

6.  Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.

Authors:  Mitsuhiko Iwamoto; Hisashi Shinohara; Akiko Miyamoto; Masaaki Okuzawa; Hideaki Mabuchi; Takehiro Nohara; Goki Gon; Masao Toyoda; Nobuhiko Tanigawa
Journal:  Int J Cancer       Date:  2003-03-10       Impact factor: 7.396

7.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

8.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

9.  High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells.

Authors:  Paolo Serafini; Rebecca Carbley; Kimberly A Noonan; Gladys Tan; Vincenzo Bronte; Ivan Borrello
Journal:  Cancer Res       Date:  2004-09-01       Impact factor: 12.701

10.  Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells.

Authors:  J Péguet-Navarro; C Moulon; C Caux; C Dalbiez-Gauthier; J Banchereau; D Schmitt
Journal:  Eur J Immunol       Date:  1994-04       Impact factor: 5.532

View more
  49 in total

Review 1.  Autophagy and cancer.

Authors:  Li Yen Mah; Kevin M Ryan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-01-01       Impact factor: 10.005

2.  Langerhans cells from human cutaneous squamous cell carcinoma induce strong type 1 immunity.

Authors:  Hideki Fujita; Mayte Suárez-Fariñas; Hiroshi Mitsui; Juana Gonzalez; Mark J Bluth; Shali Zhang; Diane Felsen; James G Krueger; John A Carucci
Journal:  J Invest Dermatol       Date:  2012-03-08       Impact factor: 8.551

3.  Quantification of blood dendritic cells in colorectal cancer patients during the course of disease.

Authors:  Giulia Orsini; Annalisa Legitimo; Alessandra Failli; Paola Ferrari; Andrea Nicolini; Roberto Spisni; Paolo Miccoli; Rita Consolini
Journal:  Pathol Oncol Res       Date:  2013-09-11       Impact factor: 3.201

Review 4.  Advancements in immune tolerance.

Authors:  Ping-Ying Pan; Junko Ozao; Zuping Zhou; Shu-Hsia Chen
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

Review 5.  Targeted immune therapy of ovarian cancer.

Authors:  Keith L Knutson; Lavakumar Karyampudi; Purushottam Lamichhane; Claudia Preston
Journal:  Cancer Metastasis Rev       Date:  2015-03       Impact factor: 9.264

6.  In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.

Authors:  Milos Arsenijevic; Marija Milovanovic; Snezana Jovanovic; Natalija Arsenijevic; Bojana Simovic Markovic; Marina Gazdic; Vladislav Volarevic
Journal:  J Biol Inorg Chem       Date:  2017-04-18       Impact factor: 3.358

Review 7.  The role of tumor microenvironment in melanoma therapy resistance.

Authors:  Rajasekharan Somasundaram; Meenhard Herlyn; Stephan N Wagner
Journal:  Melanoma Manag       Date:  2016-02-12

Review 8.  The immune system in the pathogenesis of ovarian cancer.

Authors:  Bridget Charbonneau; Ellen L Goode; Kimberly R Kalli; Keith L Knutson; Melissa S Derycke
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

9.  Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

Authors:  Michael C Schmid; Judith A Varner
Journal:  J Oncol       Date:  2010-05-16       Impact factor: 4.375

10.  Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

Authors:  Jing-Hua Huang; Song-Nan Zhang; Kyung-Ju Choi; Il-Kyu Choi; Joo-Hang Kim; Min-Geol Lee; Mingul Lee; Hoguen Kim; Chae-Ok Yun
Journal:  Mol Ther       Date:  2009-09-08       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.